Canada suspends visas for Ebola countries

Canada has decided to suspend visa applications from residents and passport-holders from West African countries in the grip of the Ebola outbreak.

The decision follows a similar decision by Australia, which drew criticism from the World Health Organization (WHO).

The ban would apply to countries with “widespread and persistent-intense transmission”, Canada said.

Liberia, Sierra Leone and Guinea are battling to contain Ebola, which has killed almost 5,000 people.

The WHO said on October 31 that 4,951 people had died during the current outbreak, with 13,567 reported cases up to October 29.

Although Canada currently has no cases of Ebola, the country’s federal citizenship ministry said “the introduction or spread of the disease would pose an imminent and severe risk to public health”.

A government spokesman said the move was less restrictive than Australia’s plan, with the ability to grant visas on a case-by-case basis retained.

Canada has decided to suspend visa applications from residents and passport-holders from West African countries in the grip of the Ebola outbreak

The ban would also not apply to Canadians travelling from the Ebola zone – allowing health workers and volunteers to return home.

There are no direct flights to Canada from the three worst-affected countries, and the numbers of annual visitors from those states is understood to be small.

The WHO opposes travel bans as a method of containing Ebola.

David Fidler, a professor at Indiana University in the US, told Canadian media that the government’s move undermined international regulations drawn up after the SARS outbreak of 2003.

“The whole thing that so many years and so many efforts and so much money was spent on just seems to be disintegrating in this Ebola panic,” he told CBC News.

Canada’s visa ban comes as trials get under way in Switzerland on the latest round of testing of an experimental vaccine.

The vaccine, jointly developed by US disease authorities and pharmaceutical company GlaxoSmithKline (GSK), is already being tested on volunteers in the US, UK and Mali.

_d_EIuzX9f4
Diane A. Wade

Diane is a perfectionist. She enjoys searching the internet for the hottest events from around the world and writing an article about it. The details matter to her, so she makes sure the information is easy to read and understand. She likes traveling and history, especially ancient history. Being a very sociable person she has a blast having barbeque with family and friends.

Recent Posts

House Panel Votes to Release Matt Gaetz Ethics Report

The US House Ethics Committee has voted to release its report on former Republican Representative…

4 days ago

ABC News to Pay $15M to Settle Trump Defamation Suit

ABC News has agreed to pay $15 million to President-elect Donald Trump to settle a…

1 week ago

South Korea’s Parliament Impeaches President Yoon Suk Yeol Following Martial Law Scandal

South Korea’s parliament has voted to impeach President Yoon Suk Yeol over his failed attempt…

1 week ago

Syria: Israeli War Planes Carry Out More Than 100 Air Strikes

Israeli war planes have carried out more than 100 air strikes in Syria on December…

2 weeks ago

Donald Trump Threatens 100% Tariff on BRICS Nations

President-elect Donald Trump has threatened to impose 100% tariffs on the BRICS countries if they…

3 weeks ago

Syria Coup: Rebels Take Control of Aleppo

Syrian troops have withdrawn from the city of Aleppo following an offensive by rebels opposed…

3 weeks ago